Tenderwize
Retour à la recherche

Dynamic purchasing system for pharmaceutical products

Městská nemocnice Ostrava, příspěvková organizace·Ostrava - Moravská Ostrava, Czech Republic·CZK 300M | EUR 12.4M·Deadline Aug 26, 2027 · 365 days left·Restricted·Supplies·DPS
Inscrivez-vous pour sauvegarderOpen documents
High value
Titre original de l'avis

Czechia – Pharmaceutical products – DYNAMICKÝ NÁKUPNÍ SYSTÉM NA NÁKUP LÉČIVÝCH PŘÍPRAVKŮ

62/100

Score d'opportunité

Needs reviewMedium complexity
SuppliesDPSOpen
Pourquoi ce score ?

Opportunité

62 / 100

Complexité

58 / 100

Facteurs de risque

The structured data deadline time (10:45 UTC) and XML notice time (12:45 local time) refer to the same moment, but bidd...

The document URLs are present, but no procurement document text was provided, so important conditions may be missing fr...

Restricted procedure — pre-qualification required

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Moderate opportunity

Faits clés

  • CZK 300M estimated value
  • Dynamic Purchasing System (DPS)
  • Supplies contract
  • 1 lot
  • Duration until Aug 2027
  • Establishment of a dynamic purchasing system for pharmaceutical products.
  • Supply of medicinal products under the DPS.
Afficher le résumé complet

This is a Czech DPS for pharmaceutical products (CPV 33600000) led by Městská nemocnice Ostrava. The structured data shows one lot, estimated at CZK 300,000,000, with electronic submission required and a deadline on 2027-08-26 10:45 UTC (XML shows 12:45 local time). Only limited notice text is available; procurement documents were not provided for analysis.

Risques

The structured data deadline time (10:45 UTC) and XML notice time (12:45 local time) refer to the same moment, but bidd...

The document URLs are present, but no procurement document text was provided, so important conditions may be missing fr...

Restricted procedure — pre-qualification required

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • The procedure is restricted.
  • The notice indicates a DPS/list contracting system.

Administrative

  • Electronic submission is required.

Acheteur

Localisation

Ostrava - Moravská Ostrava, CZE

Site web

www.mnof.cz/

Profil acheteur

Ouvrir le profil

Identifiant

00635162

Activité

Health

Lots (1)

LOT-0001

Dynamic purchasing system for pharmaceutical products

Supply lot for medicines/pharmaceutical products under a dynamic purchasing system. The lot is for deliveries in the Czech Republic, specifically the Moravian-Silesian region (CZ080). The lot value is CZK 300,000,000. The notice text indicates this is a DPS and that the second stage is not allowed to be negotiated; detailed lot scope is incomplete in the provided text.

SuppliesDPSEU fundedElectronic submissionSME suitable

EUR 12.4M

Valeur estimée

Localisation

CZ080, Czech Republic

Durée

Aug 2021 - Aug 2027

Catégorie

Pharmaceutical products

Date limite

Deadline Aug 26, 2027

Détails de la procédure

Date de publication
28 Jun 2024
Langues
Czech

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
384780-2024

Documents (1)

Document de consultation 1

Appels d'offres similaires

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3